Výsledky vyhledávání - "Lone S, Friis"

Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantation

Autor: Frederikke Schierbeck, Jann Mortensen, Niels S. Andersen, Lone S. Friis, Brian Kornblit, Søren L. Petersen, Ida Schjødt, Henrik Sengeløv

Publikováno v: Schierbeck, F, Mortensen, J, Andersen, N S, Friis, L S, Kornblit, B, Petersen, S L, Schjødt, I & Sengeløv, H 2023, ' Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantation ', European Journal of Haematology, vol. 110, no. 1, pp. 50-59 . https://doi.org/10.1111/ejh.13869

Objectives: The purpose of the study was to assess the validity of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) and of pulmonary comorbidity prior to HCT in terms of predicting non-relapse mortality (NRM) and overall sur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02132b702347f1e30f6e3ed2b4ddd5cf
https://curis.ku.dk/ws/files/328537972/European_J_of_Haematology_2022_Schierbeck_Pulmonary_function_is_a_strong_predictor_of_2_year_overall_survival_and.pdf

Zobrazit plný text záznamu

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Autor: Lars K, Gjærde, Niels S, Andersen, Lone S, Friis, Brian, Kornblit, Søren L, Petersen, Ida, Schjødt, Sisse R, Ostrowski, Henrik, Sengeløv

Publikováno v: Bone marrow transplantation. 55(7)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::62d62f0d4100cbaa8e8665922e97fec7
https://pubmed.ncbi.nlm.nih.gov/31772337

Zobrazit plný text záznamu

Extramedullary disease in patients with acute myeloid leukemia assessed by (18)F-FDG PET

Autor: Henrik Petersen, Henrik Frederiksen, Lone S. Friis, Maria Steenhof, Claus Werenberg Marcher, Anne-Sofie Weindel Ibar Cribe

Publikováno v: Cribe, A S, Steenhof, M, Marcher, C W, Petersen, H, Frederiksen, H & Friis, L S 2013, ' Extramedullary disease in patients with acute myeloid leukemia assessed by (18)F-FDG PET ', European Journal of Haematology, vol. 90, no. 4, pp. 273-278 . https://doi.org/10.1111/ejh.12085

Background Prevalence of extramedullary disease (EMD) in acute myeloid leukemia (AML) at the time of diagnosis is unknown. Previous estimates range from 2.5% to 30.5% and are usually based on clinical examination. This may cause an under diagnosis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb9c580a1e5f4f62bf1fd55292fc468
https://doi.org/10.1111/ejh.12085

Zobrazit plný text záznamu

Plný text ve formátu HTML

NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression*

Autor: Thomas Kielsgaard Kristensen, Lone S. Friis, Olav J. Bergmann, Birgitte Preiss, Michael Boe Møller

Publikováno v: European Journal of Haematology. 87:400-408

Mutation in the NPM1 gene occurs in 60% of acute myeloid leukaemia (AML) patients with normal karyotype. NPM1 mutation is potentially a superior minimal residual disease (MRD) marker compared to WT1 gene overexpression by being specific to the malign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::195ff95778269bc18acba23ebc67b413
https://doi.org/10.1111/j.1600-0609.2011.01673.x

Zobrazit plný text záznamu

Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML

Autor: Birgitte S, Preiss, Olav J, Bergmann, Olav J, Bergman, Lone S, Friis, Anne G, Sørensen, Michael, Frederiksen, Ole V, Gadeberg, Torben, Mourits-Andersen, Birthe, Oestergaard, Gitte B, Kerndrup, Hanne, Vestergaard

Publikováno v: Preiss, B S, Bergman, O J, Friis, L S, Sørensen, A, Frederiksen, M, Gadeberg, O V, Mourits-Andersen, T, Østergaard, B, Kerndrup, G B & AML Study Group of Southern Denmark 2010, ' Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML ', Cancer Genetics and Cytogenetics, vol. 202, no. 2, pp. 108-22 . https://doi.org/10.1016/j.cancergencyto.2010.06.013

During a 15-year period, 161 adult patients were diagnosed with secondary acute myeloid leukemia (s-AML) in the region of Southern Denmark. In 73 patients, the AML diagnosis was preceded by myelodysplastic syndrome (MDS-AML), in 31 patients by an ant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5810dbcb159286eaec4bac0e0f722edc
https://doi.org/10.1016/j.cancergencyto.2010.06.013

Zobrazit plný text záznamu

Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients:A rationale for combined targeting of PD-1 and DNA methylation

Autor: Marianne Bach Treppendahl, Anni Skovbo, Andreas Due Ørskov, Lone S. Friis, Mette Holm, Marianne Hokland, Kirsten Grønbæk

Publikováno v: Ørskov, A D, Treppendahl, M B, Skovbo, A, Holm, M S, Friis, L S, Hokland, M & Grønbæk, K 2015, ' Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients : A rationale for combined targeting of PD-1 and DNA methylation ', OncoTarget, vol. 6, no. 11, pp. 9612-26 . https://doi.org/10.18632/oncotarget.3324
Scopus-Elsevier
Ørskov, A D, Treppendahl, M B, Skovbo, A, Holm, M S, Friis, L S, Hokland, M & Gronbaek, K 2015, ' Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients : A rationale for combined targeting of PD-1 and DNA methylation ', OncoTarget, vol. 6, no. 11, pp. 9612-9626 . https://doi.org/10.18632/oncotarget.3324
Oncotarget

// Andreas D. Orskov 1, * , Marianne B. Treppendahl 1, * , Anni Skovbo 2, 3 , Mette S. Holm 4 , Lone S. Friis 1, 5 , Marianne Hokland 2 , Kirsten Gronbaek 1 1 Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ec2a1122daad8268bf08082b083d01d
https://pure.au.dk/portal/da/publications/hypomethylation-and-upregulation-of-pd1-in-t-cells-by-azacytidine-in-mdsaml-patients(9d16c417-e88f-44b0-846b-8534ad5d0de3).html

Zobrazit plný text záznamu

Systemic mastocytosis is uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia

Autor: Hanne Vestergaard, Lone S. Friis, Sigurd Broesby-Olsen, Michael Boe Møller, Birgitte Preiss, Thomas Kielsgaard Kristensen

Publikováno v: Kristensen, T, Preiss, B, Broesby-Olsen, S, Vestergaard, H, Friis, L & Boe Møller, M 2012, ' Systemic mastocytosis uncommon in KIT D816V mutation positive core-binding factor acute myeloid leukemia ', Leukemia and Lymphoma, vol. 53, no. 7, pp. 1338-44 . https://doi.org/10.3109/10428194.2011.647314

The KIT D816V mutation is detected in the vast majority of adult cases of systemic mastocytosis (SM). The mutation is also frequently detected in core-binding factor acute myeloid leukemia (CBF AML) defined by the presence of t(8;21)(q22;q22); RUNX1-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e5c07e6b43f0a0621f8e6a6f5970139
https://pubmed.ncbi.nlm.nih.gov/22145956

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání